Freenome
Blood-based early cancer detection using multiomics and AI
About Freenome
<cite index="25-1,25-3">Freenome is a biotechnology company dedicated to early cancer detection through a comprehensive multiomics platform that uses a standard blood draw, combining molecular biology, computational biology, and machine learning to develop noninvasive blood tests to detect cancer at its earliest, most treatable stages</cite>.</description> <parameter name="industry">Biotechnology Research
Headquarters
Brisbane, California
Company size
201-500
Founded
2014
What we do
blood-based cancer screeningmultiomics platformmachine learningearly cancer detectionmolecular diagnosticscancer diagnostic tests
Interested in Freenome?
Join our talent pool to be considered for future opportunities.